New neurons are supplied throughout life in most mammals in two regions of the brain: the dentate gyrus of the hippocampus, by locally residing neural stem cells, and the olfactory bulb, by neural stem cells present in the lateral ventricle wall. The new neurons confer plasticity to the circuitry and increasing evidence has established a role for adult neurogenesis in specific brain functions. The discovery of neural stem cells and neurogenesis in the adult mammalian central nervous system changed our view of the plasticity and function of the brain and spurred enthusiasm for trying to harness their regenerative potential in new therapies for conditions such as depression, stroke, spinal cord injury, and Parkinson's disease. Our understanding of neural stem cells has increased dramatically over the past few years, but there are still many major gaps, some of which are the focus of our discussion here.
Neural Stem Cell Heterogeneity
Stem cells are notoriously difficult to identify, and we have witnessed a gradual homing in on bona fide stem cells in many tissues. This progress has been accompanied by a realization that stem cell populations are often heterogeneous within a tissue and that several distinct stem cells for the same lineage can coexist. For example, in the skin, intestine, and hematopoietic system, there are stem cells that may be in different states of activity or dormancy or may have different roles in homeostasis and regeneration.
It will be necessary to develop a detailed characterization of the full repertoire of neurogenic cells in the adult brain to understand the process of adult neurogenesis and to potentially modulate it in therapeutic strategies. In most studies, the properties of neural stem cells are interrogated at a population level rather than at the clonal level, resulting in the analysis of potentially mixed populations, making it difficult to detect heterogeneity ( Figure 1 ). Nevertheless, it is already clear that heterogeneity does exist. For example, in the hippocampus, there are at least two morphologically distinguishable types of astrocytes that give rise to neurons, radial and horizontal, but their lineage relationship is still subject of debate. There is also conflicting evidence about whether hippocampal astrocytes are self-renewing or exhausted during the process of generating new neurons (Bonaguidi et al., 2011; Encinas et al., 2011) . These apparently contradictory results might reflect the coexistence of several stem cell populations with different properties. In the ventricle wall there are indications that astrocytes may have different activity states marked by EGFR expression. In several organs, there are indications that progenitor cells may be able to revert to a stem cell state, and it has been suggested that EGF may induce dedifferentiation of transit amplifying cells in the neural lineage to stem cells. Moreover, neural stem cells located at different positions along the ventricle wall and rostral migratory stream give rise to different repertoires of olfactory bulb neurons (Lledo et al., 2008) .
Detecting heterogeneity within a population is virtually impossible without using clonal labeling or fate mapping strategies to mark distinct subpopulations. Thus, although there are clear indications of neural stem cell heterogeneity and we have already learned about some aspects of it using such approaches, it seems likely that there is much more diversity still to discover. How do we identify and characterize subpopulations that we do not even know exist? Neuroscience may perhaps be able to learn from genetic fate mapping strategies used in other organs, which have been extremely helpful in identifying diversity. As our marker and genetic reagent tool boxes grow, we are likely to continue finding new features of neural stem cells.
Latent Neural Stem Cell Activity
It became clear during early studies of neural stem cells not only that cells with in vitro neural stem cell properties are found in neurogenic niches, but also that they are in fact present in most major subdivisions of the adult central nervous system. Moreover, injury endows additional cells with in vitro neural stem cell properties (Barnabé -Heider et al., 2010; Buffo et al., 2008) . Thus, in addition to the neural stem cells that are responsible for physiological adult neurogenesis, there are other cells that may have similar potential but are largely dormant (Figure 1 ). Which are these latent neural stem cells, what is their in vivo function, and can they be induced to replace lost cells?
Cortical astrocytes gain in vitro neural stem cell properties after injury (Buffo et al., 2008) . However, there is no evidence that they produce cells other than astrocytes outside the neurogenic niches in vivo, and their main function after injury may be to participate in the formation of a glial scar. We do not know today what distinguishes a neurogenic astrocytic stem cell from an astrocyte with latent stem cell or neurogenic potential. It is probably in part regulated cell intrinsically, as neurogenic and nonneurogenic astrocytes are intermingled in the neurogenic niches. Spinal cord ependymal cells have in vitro neural stem cell properties but are largely dormant and do not generate other cell types in vivo in the absence of injury (Figure 1) . In response to injury, their proliferation is dramatically increased, a much larger number of them display in vitro neural stem cell properties, and they constitute the main source of new glial cells in the injured spinal cord (Barnabé -Heider et al., 2010) . Forebrain ependymal cells lining the lateral walls are completely quiescent but can give rise to astrocytes and neuroblasts in response to stroke. However, unlike spinal cord ependymal cells, they do not self-renew, and instead are consumed in the process of generating progeny (Carlé n et al., 2009 ). Thus, among these heterogeneous latent cells, so far there is only evidence that the cells in the neurogenic lateral ventricle wall niche can generate neuronal lineage cells in vivo.
Heterotopic transplantation experiments have indicated that the neurogenic capacity of adult neural stem cells is determined, at least in part, by their extracellular molecular environment. Unleashing latent neurogenic potential outside of normal neurogenic regions is a tantalizing proposition, but a major limiting factor may be the capacity of new neurons to integrate in regions outside of areas that are normally neurogenic. In lower vertebrates, such as the newt, neurons can be regenerated after lesions by latent stem/progenitor cells even in normally nonneurogenic regions. Understanding the regenerative mechanisms in lower vertebrates could potentially shed light on, and suggest ways to overcome, the restrictions that exist in the mammalian nervous system.
Although most attention is focused on potential therapeutic strategies that involve the generation of new neurons, it is also attractive to consider the possibility of influencing gliogenesis. Glial cells support neuronal function in many ways, and in some neural stem cell transplantation experiments the beneficial effect on functional recovery is mediated by glial differentiation, rather than by neurons. Demyelination in multiple sclerosis and many other types of injuries results in neuronal malfunction and, over time, neuronal degeneration if the axon is not remyelinated. Endogenous neural stem cells give rise mainly to scar-forming astrocytes and few remyelinating oligodendrocytes after spinal cord injury (Barnabé -Heider et al., 2010) . It is appealing to look at influencing gliogenesis, for example, to promote differentiation to remyelinating oligodendrocytes at the expense of scar forming astrocytes.
Understanding and Mending the Human Brain
From the outset, enthusiasm in the neural stem cell field was buoyed by the pros-pect of developing new therapies for neurological and psychiatric diseases. Neuronal replacement by cell transplantation has been explored intensively over recent years, and cell replacement from endogenous sources is an attractive alternative. However, the extent to which findings made in the mouse and other mammals will translate to human settings still remains largely unclear. It will therefore be important to establish the extent of neurogenesis in the adult human brain in normal and pathological situations to understand whether this process could contribute to normal brain function and whether alterations in it may be related to pathology. A seminal study by Eriksson, Gage, and colleagues demonstrated BrdU labeling in hippocampal neurons in a group of cancer patients that received the labeled nucleotide for disease staging purposes, establishing the presence of adult neurogenesis in humans (Eriksson et al., 1998) . However, this analysis did not allow quantitative assessment of the extent of neurogenesis or insights as to whether the process may be affected by pathology. Indications of the extent of neurogenesis can be inferred from the number of neuroblasts in a given region. The number of cells with neuroblast markers drops precipitously in the first few months after birth in humans, with similar kinetics and to a similar extent in the hippocampus and subventricular zone (Figure 2) , leaving only miniscule apparent numbers of neuroblasts after the first year (Knoth et al., 2010; Sanai et al., 2011) . These low Active neural stem cell niches in the mouse dentate gyrus and lateral ventricle (LV) wall, showing astrocyte-like stem cells labeled for glial fibrillary acidic protein (GFAP) and the SRY-BOX 2 (Sox2) transcription factor, and neuroblasts expressing doublecortin (DCX) (Bonaguidi et al., 2011; Lledo et al., 2008) . Latent neural stem cell niches in the adult spinal cord and cortex showing ependymal cells lining the central canal (CC) labeled for Sox2 but negative for GFAP and parenchymal astrocytes expressing GFAP and Sox2, respectively (Barnabé -Heider et al., 2010; Buffo et al., 2008) . Scale bar represents 20 mm. numbers could suggest that adult neurogenesis is unlikely to be functionally relevant in the adult human brain. However, one should interpret these data with some caution, as they could represent either an overestimate of the number of functionally active neural stem cells or an underestimate if there are other cells that do not express the tested markers. Moreover, computational modeling has suggested that even small numbers of new neurons can have a significant influence on overall circuitry. In addition, even if neurogenesis in adult humans is normally very limited, it could still be activated in pathological situations. Retrospective 14 C birth dating allows a direct measurement of the age of a cell population, and this has established that there is minimal, if any, adult olfactory bulb neurogenesis in humans (Bergmann et al., 2012) . One may argue that humans depend to a small degree on olfaction, and that hippocampal neurogenesis may be more relevant, but the similar dynamics of neuroblast generation in both neurogenic niches in humans raises the question of whether there may be any functionally relevant degree of neurogenesis in the hippocampus.
Adult neurogenesis has advanced from a controversial suggestion to having established roles in brain function in rodents. As we are delineating the normal extent and understanding the mechanisms regulating this process, one of the main goals for the future remains to assess whether it is possible to influence neural stem cells to replace cells in disease.
